Dyne Therapeutics is dedicated to improving the lives of individuals with genetically driven neuromuscular diseases by developing therapeutics targeting muscle and the central nervous system. The company advances clinical programs for myotonic dystrophy type 1 (DM1) and Duchenne muscular dystrophy (DMD), while also pursuing preclinical research for facioscapulohumeral muscular dystrophy (FSHD) and Pompe disease. Dyne's mission is to deliver functional improvement, making a significant impact on affected individuals, families, and communities.
Dyne Therapeutics is seeking a Senior Director of Franchise Counsel to lead legal guidance for clinical therapies and brand commercialization. This role involves advising on regulatory compliance, pricing strategies, and a range of legal matters impacting launches and growth. The ideal candidate will have a strong background in FDA regulations, U.S. healthcare law, and experience with PhRMA and anti-kickback statutes.
Dyne Therapeutics is dedicated to improving the lives of individuals with genetically driven neuromuscular diseases by developing therapeutics targeting muscle and the central nervous system. The company advances clinical programs for myotonic dystrophy type 1 (DM1) and Duchenne muscular dystrophy (DMD), while also pursuing preclinical research for facioscapulohumeral muscular dystrophy (FSHD) and Pompe disease. Dyne's mission is to deliver functional improvement, making a significant impact on affected individuals, families, and communities.
Dianthus Therapeutics, Inc.